Company news
Mabion Sa (GPW:MAB) news
Mabion Sa news releases on 6ix. Latest, Aug 26, 2026: Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Press releases & updates
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
August 26, 2026
Mabion S A : Other information to the quarterly report of Mabion S.A. for Q1 2026
May 19, 2026
Mabion S A : Interim condensed financial statements for the 3-month period ended 31 March 2026
May 19, 2026
Mabion S A : Financial statements for the financial year ended 31 December 2025
April 29, 2026
Mabion S A : Presentation of financial results for FY 2025 – Mabion
April 28, 2026
MABION S A : Directors’ Report for the year 2025
April 28, 2026
Mabion S A : Directors report for the year 2025
April 28, 2026
MABION S A : Condensed interim financial statements as at and for the period of 3 months and 9 months ended 30 September 2025
December 4, 2025
Mabion S A : Presentation of financial results for Q3 2025 – Mabion
December 2, 2025
Mabion S A : Other information to the quarterly report of Mabion S.A. for Q3 2025
December 1, 2025
Mabion S A : Condensed Interim Financial Statements for the Period of 6 months ended 30 June 2025
October 8, 2025
Mabion S A : Condensed interim financial statements for the period of 3 months ended 31 March 2025
June 18, 2025
Mabion S A : Directors report for the year 2024
June 16, 2025
Mabion S A : Other information to the quarterly report of Mabion S.A. for the first quarter of 2025
June 13, 2025
Mabion S A : Financial statements for the financial year ended 31 December 2024
May 9, 2025
Mabion S A : Other information to the quarterly report of Mabion S.A. for Q3 2024
October 29, 2024
Mabion S A : Condensed interim financial statements as at and for the period of 3 months and 9 months ended 30 September 2024
October 29, 2024
Mabion S A : Condensed interim financial statements for the period of 3 months ended 31 March 2024
May 14, 2024